TRIBUNNEWS.COM, JAKARTA – Chairman of the Handling Committee Covid-19 and National Economic Recovery Airlangga Hartarto denied reports that Indonesia could not buy vaccines Covid-19 production AstraZeneca origin UK.
According to Airlangga, the information was not completely correct.
This was conveyed by Airlangga during a talk show entitled Update KPCPEN: Vaccine Safety Principles Covid-19 via BNPB Indonesia’s YouTube broadcast, Tuesday (27/10/2020).
“The news is not entirely true. Because we have not decided yet,” said Airlangga.
Also read: Philippines Will Not Beg for Covid-19 Vaccine, President Duterte: We Will Pay
The Coordinating Minister for Economic Affairs explained, vaccines AstraZeneca is one of the vaccine candidates whose research is carried out in other countries.
Although, he said the price of the vaccine was the closest to the price that was affordable to the public.
In addition, the excess of vaccines AstraZeneca able to ensure the production of large volumes of vaccines.
However, said Airlangga, the availability of this vaccine cannot be held in the near future.
“Therefore, the President’s directions for vaccines are like AstraZeneca, Novavax and others are still being reviewed and of course later seen in accordance with the existing needs in Indonesia and also the future cooperation, “he explained.
–
